Medical data informatics company Clinerion has expanded into Hungary, adding the University of Debrecen to its international patient network, which it said will help to bring treatments to patients in Hungary faster.
The university’s Clinical Center is currently running more than 360 trials. It services over 56,000 patients in Debrecen, Hungary, and has study sites dedicated to anaesthesiology and intensive care, internal medicine, dermatology, paediatrics, cardiology, neurology, oncology, orthopaedics, pathology, psychiatry, pulmonology, rheumatology, surgery, ophthalmology, obstetrics and gynaecology, and urology. Its activities are overseen by its Coordination Center for Drug Development.
Professor Dr Dénes Páll, Director of the centre, said that the primary mission of the Coordination Center for Drug Development is to strategically and operationally support clinical trials to be implemented at the University of Debrecen. “We aim to foster collaborative relationships with all study sponsors and to develop future key and strategic partnerships with all current and potential partners based on professionalism and mutual benefit,” he said. “We are committed to sharing relevant knowledge about clinical trials with patients, their family members, and the public in general, as well as other healthcare professionals to promote the added value of personal participation in such trials. Additionally, we focus attention on the implementation of initiatives coming from individual sites and principal investigators concerning improving efficacy, efficiency and patient centricity of the clinical trial process.”
Ian Rentsch, CEO of Clinerion, commented on Clinerion’s new addition: “We are very pleased to bring treatments and medicines to patients in Hungary faster, and also allowing clinical studies in the country to be more efficient. The University of Debrecen, with its wide range of therapeutic areas and deep expertise, will be a great addition to Clinerion’s global site network.”